Status:

COMPLETED

The Effect of Neuromuscular Blockade on the Composite Variability Index (CVI) During Laryngoscopy

Lead Sponsor:

Medtronic - MITG

Conditions:

Anesthesia

Neuromuscular Blockade

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

The Bispectral Index (BIS) monitor is used in many operating rooms to provide information to the anesthesiologist about a patient's level of consciousness. The Composite Variability Index (CVI) is a n...

Detailed Description

Consented subjects randomized to one of four doses of rocuronium will be transported to the operating room and be connected to routine monitors that included a BIS (Covidien), M-Entropy sensor (GE Hea...

Eligibility Criteria

Inclusion

  • American Society of Anesthesia (ASA) physical status class I or II.
  • Body mass index between 18 and 35 kg m-2.
  • No use of psychotropic or neuropsychiatric medications.
  • A airway assessment with no indication of a difficult intubation including a class I or II Mallampati airway and a mandible-to-hyoid distance of greater than three fingerbreadths.
  • Age between 18-75 years.

Exclusion

  • Does not meet inclusion criteria.

Key Trial Info

Start Date :

June 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2013

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT01450813

Start Date

June 1 2009

End Date

December 1 2013

Last Update

May 12 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Fletcher Allen Health Care

Burlington, Vermont, United States, 05405